Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$512.12 - $623.61
Next Earnings Date
Jul 22 2025 (Estimate)
Next Earnings Date
Jul 22 2025 (Est.)
Latest price
Market Cap | $8.56B |
EV | $8.52B |
Shares Outstanding | 14.77M |
Beta | 0.49 |
Analyst Rating | BUY |
Analyst Target Price | $675.00 |
P/E 2025E | 23.26x |
P/Revenue 2025E | 3.26x |
Revenue | 4.40% |
EPS | 6.20% |
Operating Cash Flow | 10.60% |
Free Cash Flow | 9.90% |
Revenue | 6.90% |
EPS | 7.50% |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | 12.84% |
ROE 2025E | 30.18% |
ROCE 2024 | 27.12% |
DPS 2025E | $2.05 |
Payout Ratio 2025E | 8.15% |
Div. Yield 2025E | 0.38% |
DPS Last 3Y CAGR | 4.90% |
Price
%
1M
3M
6M
1Y
3Y
5Y
Chemed Corporation
CHE
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
McNamara, Kevin
Employees
15,695
Website
www.chemed.comIPO Date
1973-05-03
Headquarters
255 East Fifth Street, Suite 2600, Cincinnati, Ohio, 45202-4726, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved